je.st
news
Tag: therapy
Merck Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for KEYTRUDA (pembrolizumab) in Classical Hodgkin Lymphoma (cHL)
2016-04-18 14:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Fourth Designation for KEYTRUDA Follows Breakthrough Status in Advanced Melanoma, Non-Small Cell Lung Cancer, and Colorectal Cancer KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, for the treatment of patients with relapsed or refractory classical Hodgkin lymphoma (cHL). This is the fourth Breakthrough Therapy Designation granted for KEYTRUDA. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558An Phan, 908-255-6325orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: food
administration
classical
drug
Calgary International Airport launches dog therapy programme
2016-04-13 01:00:00| Airport Technology
Canada's Calgary Airport Authority has introduced a new Pre-Board Pals programme to improve passengers' experience at Calgary International Airport (YYC).
Tags: international
dog
programme
therapy
GSK receives European and CHMP approval for stem cell gene therapy
2016-04-02 23:10:57| Biotech - Topix.net
GlaxoSmithKline has been given encouraging support for a stem cell gene therapy that uses an individual patient's own cells to treat a very rare immunodeficiency disorder in children. The Committee for Medicinal Products for Human Use of the European Medicines Agency , in conjunction with the Committee for Advanced Therapies , has issued a positive opinion recommending marketing authorisation for Strimvelis, GSK's brand name for the medicine to treat the ADA-SCID disorder.
Tags: cell
european
approval
therapy
Stroke patients show higher recovery in MultiStem therapy studied at UH Case Med Center
2016-02-25 19:01:04| Biotech - Topix.net
Data presented by the biotech company Athersys indicate that stroke patients treated by an adult stem cell therapy called MultiStem did significantly better than others who received a placebo one year after treatment. The results are from a Phase 2 study involving clinical sites in the United States and the United Kingdom, including University Hospitals Case Medical Center.
Your Body: Paying for Therapy Out of Pocket
2016-02-17 11:53:14| Biotech - Topix.net
How much are you willing to pay for therapies not covered by insurance? According to a recent study from the Centers for Disease Control and Prevention, a lot. Acupuncture, chiropractic and massage therapy have all grown in popularity between 2002 and 2012.
Tags: body
pocket
therapy
paying
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] next »